Phase II testing of Alexion's C5 complement inhibitor also begins in renal diseases Aug. 12, 1999 No Comments
BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy Aug. 11, 1999 No Comments
NS-49: preclinical pharmacokinetics of potential new agent for stress incontinence July 28, 1999 No Comments
Nitrosylated alpha-adrenoceptor antagonists as potential agents for impotence July 27, 1999 No Comments
RSS